Direct-to-consumer Genetic Health Sequencing Market Size, Share, Growth, and Industry Analysis, By Types (Diagnostic Screening, PGD Relationship Testing), By Applications Covered (Online, Offline), Regional Insights and Forecast to 2034

Detailed TOC of Global Direct-to-consumer Genetic Health Sequencing Report, Competitive Landscape, Market Size, Regional Status and Prospect

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Direct-to-consumer Genetic Health Sequencing Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Diagnostic Screening
1.2.3 PGD Relationship Testing
1.3 Market by Application
1.3.1 Global Direct-to-consumer Genetic Health Sequencing Market Growth by Application: 2018 VS 2022 VS 2034
1.3.2 Online
1.3.3 Offline
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Direct-to-consumer Genetic Health Sequencing Market Perspective (2018-2034)
2.2 Direct-to-consumer Genetic Health Sequencing Growth Trends by Region
2.2.1 Global Direct-to-consumer Genetic Health Sequencing Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Direct-to-consumer Genetic Health Sequencing Historic Market Size by Region (2018-2025)
2.2.3 Direct-to-consumer Genetic Health Sequencing Forecasted Market Size by Region (2024-2034)
2.3 Direct-to-consumer Genetic Health Sequencing Market Dynamics
2.3.1 Direct-to-consumer Genetic Health Sequencing Industry Trends
2.3.2 Direct-to-consumer Genetic Health Sequencing Market Drivers
2.3.3 Direct-to-consumer Genetic Health Sequencing Market Challenges
2.3.4 Direct-to-consumer Genetic Health Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Direct-to-consumer Genetic Health Sequencing Players by Revenue
3.1.1 Global Top Direct-to-consumer Genetic Health Sequencing Players by Revenue (2018-2025)
3.1.2 Global Direct-to-consumer Genetic Health Sequencing Revenue Market Share by Players (2018-2025)
3.2 Global Direct-to-consumer Genetic Health Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Direct-to-consumer Genetic Health Sequencing Revenue
3.4 Global Direct-to-consumer Genetic Health Sequencing Market Concentration Ratio
3.4.1 Global Direct-to-consumer Genetic Health Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Direct-to-consumer Genetic Health Sequencing Revenue in 2022
3.5 Direct-to-consumer Genetic Health Sequencing Key Players Head office and Area Served
3.6 Key Players Direct-to-consumer Genetic Health Sequencing Product Solution and Service
3.7 Date of Enter into Direct-to-consumer Genetic Health Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Direct-to-consumer Genetic Health Sequencing Breakdown Data by Type
4.1 Global Direct-to-consumer Genetic Health Sequencing Historic Market Size by Type (2018-2025)
4.2 Global Direct-to-consumer Genetic Health Sequencing Forecasted Market Size by Type (2024-2034)
5 Direct-to-consumer Genetic Health Sequencing Breakdown Data by Application
5.1 Global Direct-to-consumer Genetic Health Sequencing Historic Market Size by Application (2018-2025)
5.2 Global Direct-to-consumer Genetic Health Sequencing Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Direct-to-consumer Genetic Health Sequencing Market Size (2018-2034)
6.2 North America Direct-to-consumer Genetic Health Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2034
6.3 North America Direct-to-consumer Genetic Health Sequencing Market Size by Country (2018-2025)
6.4 North America Direct-to-consumer Genetic Health Sequencing Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Direct-to-consumer Genetic Health Sequencing Market Size (2018-2034)
7.2 Europe Direct-to-consumer Genetic Health Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2034
7.3 Europe Direct-to-consumer Genetic Health Sequencing Market Size by Country (2018-2025)
7.4 Europe Direct-to-consumer Genetic Health Sequencing Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Direct-to-consumer Genetic Health Sequencing Market Size (2018-2034)
8.2 Asia-Pacific Direct-to-consumer Genetic Health Sequencing Market Growth Rate by Region: 2018 VS 2022 VS 2034
8.3 Asia-Pacific Direct-to-consumer Genetic Health Sequencing Market Size by Region (2018-2025)
8.4 Asia-Pacific Direct-to-consumer Genetic Health Sequencing Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Direct-to-consumer Genetic Health Sequencing Market Size (2018-2034)
9.2 Latin America Direct-to-consumer Genetic Health Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2034
9.3 Latin America Direct-to-consumer Genetic Health Sequencing Market Size by Country (2018-2025)
9.4 Latin America Direct-to-consumer Genetic Health Sequencing Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Direct-to-consumer Genetic Health Sequencing Market Size (2018-2034)
10.2 Middle East & Africa Direct-to-consumer Genetic Health Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2034
10.3 Middle East & Africa Direct-to-consumer Genetic Health Sequencing Market Size by Country (2018-2025)
10.4 Middle East & Africa Direct-to-consumer Genetic Health Sequencing Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 23andMe
11.1.1 23andMe Company Detail
11.1.2 23andMe Business Overview
11.1.3 23andMe Direct-to-consumer Genetic Health Sequencing Introduction
11.1.4 23andMe Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.1.5 23andMe Recent Development
11.2 MyHeritage
11.2.1 MyHeritage Company Detail
11.2.2 MyHeritage Business Overview
11.2.3 MyHeritage Direct-to-consumer Genetic Health Sequencing Introduction
11.2.4 MyHeritage Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.2.5 MyHeritage Recent Development
11.3 LabCorp
11.3.1 LabCorp Company Detail
11.3.2 LabCorp Business Overview
11.3.3 LabCorp Direct-to-consumer Genetic Health Sequencing Introduction
11.3.4 LabCorp Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.3.5 LabCorp Recent Development
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Detail
11.4.2 Myriad Genetics Business Overview
11.4.3 Myriad Genetics Direct-to-consumer Genetic Health Sequencing Introduction
11.4.4 Myriad Genetics Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.4.5 Myriad Genetics Recent Development
11.5 Ancestry.com
11.5.1 Ancestry.com Company Detail
11.5.2 Ancestry.com Business Overview
11.5.3 Ancestry.com Direct-to-consumer Genetic Health Sequencing Introduction
11.5.4 Ancestry.com Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.5.5 Ancestry.com Recent Development
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Detail
11.6.2 Quest Diagnostics Business Overview
11.6.3 Quest Diagnostics Direct-to-consumer Genetic Health Sequencing Introduction
11.6.4 Quest Diagnostics Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.6.5 Quest Diagnostics Recent Development
11.7 Gene By Gene
11.7.1 Gene By Gene Company Detail
11.7.2 Gene By Gene Business Overview
11.7.3 Gene By Gene Direct-to-consumer Genetic Health Sequencing Introduction
11.7.4 Gene By Gene Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.7.5 Gene By Gene Recent Development
11.8 DNA Diagnostics Center
11.8.1 DNA Diagnostics Center Company Detail
11.8.2 DNA Diagnostics Center Business Overview
11.8.3 DNA Diagnostics Center Direct-to-consumer Genetic Health Sequencing Introduction
11.8.4 DNA Diagnostics Center Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.8.5 DNA Diagnostics Center Recent Development
11.9 Invitae
11.9.1 Invitae Company Detail
11.9.2 Invitae Business Overview
11.9.3 Invitae Direct-to-consumer Genetic Health Sequencing Introduction
11.9.4 Invitae Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.9.5 Invitae Recent Development
11.10 IntelliGenetics
11.10.1 IntelliGenetics Company Detail
11.10.2 IntelliGenetics Business Overview
11.10.3 IntelliGenetics Direct-to-consumer Genetic Health Sequencing Introduction
11.10.4 IntelliGenetics Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.10.5 IntelliGenetics Recent Development
11.11 Ambry Genetics
11.11.1 Ambry Genetics Company Detail
11.11.2 Ambry Genetics Business Overview
11.11.3 Ambry Genetics Direct-to-consumer Genetic Health Sequencing Introduction
11.11.4 Ambry Genetics Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.11.5 Ambry Genetics Recent Development
11.12 Living DNA
11.12.1 Living DNA Company Detail
11.12.2 Living DNA Business Overview
11.12.3 Living DNA Direct-to-consumer Genetic Health Sequencing Introduction
11.12.4 Living DNA Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.12.5 Living DNA Recent Development
11.13 EasyDNA
11.13.1 EasyDNA Company Detail
11.13.2 EasyDNA Business Overview
11.13.3 EasyDNA Direct-to-consumer Genetic Health Sequencing Introduction
11.13.4 EasyDNA Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.13.5 EasyDNA Recent Development
11.14 Pathway Genomics
11.14.1 Pathway Genomics Company Detail
11.14.2 Pathway Genomics Business Overview
11.14.3 Pathway Genomics Direct-to-consumer Genetic Health Sequencing Introduction
11.14.4 Pathway Genomics Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.14.5 Pathway Genomics Recent Development
11.15 Centrillion Technology
11.15.1 Centrillion Technology Company Detail
11.15.2 Centrillion Technology Business Overview
11.15.3 Centrillion Technology Direct-to-consumer Genetic Health Sequencing Introduction
11.15.4 Centrillion Technology Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.15.5 Centrillion Technology Recent Development
11.16 Xcode
11.16.1 Xcode Company Detail
11.16.2 Xcode Business Overview
11.16.3 Xcode Direct-to-consumer Genetic Health Sequencing Introduction
11.16.4 Xcode Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.16.5 Xcode Recent Development
11.17 Color Genomics
11.17.1 Color Genomics Company Detail
11.17.2 Color Genomics Business Overview
11.17.3 Color Genomics Direct-to-consumer Genetic Health Sequencing Introduction
11.17.4 Color Genomics Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.17.5 Color Genomics Recent Development
11.18 Anglia DNA Services
11.18.1 Anglia DNA Services Company Detail
11.18.2 Anglia DNA Services Business Overview
11.18.3 Anglia DNA Services Direct-to-consumer Genetic Health Sequencing Introduction
11.18.4 Anglia DNA Services Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.18.5 Anglia DNA Services Recent Development
11.19 African Ancestry
11.19.1 African Ancestry Company Detail
11.19.2 African Ancestry Business Overview
11.19.3 African Ancestry Direct-to-consumer Genetic Health Sequencing Introduction
11.19.4 African Ancestry Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.19.5 African Ancestry Recent Development
11.20 Canadian DNA Services
11.20.1 Canadian DNA Services Company Detail
11.20.2 Canadian DNA Services Business Overview
11.20.3 Canadian DNA Services Direct-to-consumer Genetic Health Sequencing Introduction
11.20.4 Canadian DNA Services Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.20.5 Canadian DNA Services Recent Development
11.21 DNA Family Check
11.21.1 DNA Family Check Company Detail
11.21.2 DNA Family Check Business Overview
11.21.3 DNA Family Check Direct-to-consumer Genetic Health Sequencing Introduction
11.21.4 DNA Family Check Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.21.5 DNA Family Check Recent Development
11.22 Alpha Biolaboratories
11.22.1 Alpha Biolaboratories Company Detail
11.22.2 Alpha Biolaboratories Business Overview
11.22.3 Alpha Biolaboratories Direct-to-consumer Genetic Health Sequencing Introduction
11.22.4 Alpha Biolaboratories Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.22.5 Alpha Biolaboratories Recent Development
11.23 Test Me DNA
11.23.1 Test Me DNA Company Detail
11.23.2 Test Me DNA Business Overview
11.23.3 Test Me DNA Direct-to-consumer Genetic Health Sequencing Introduction
11.23.4 Test Me DNA Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.23.5 Test Me DNA Recent Development
11.24 23 Mofang
11.24.1 23 Mofang Company Detail
11.24.2 23 Mofang Business Overview
11.24.3 23 Mofang Direct-to-consumer Genetic Health Sequencing Introduction
11.24.4 23 Mofang Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.24.5 23 Mofang Recent Development
11.25 Genetic Health
11.25.1 Genetic Health Company Detail
11.25.2 Genetic Health Business Overview
11.25.3 Genetic Health Direct-to-consumer Genetic Health Sequencing Introduction
11.25.4 Genetic Health Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.25.5 Genetic Health Recent Development
11.26 DNA Services of America
11.26.1 DNA Services of America Company Detail
11.26.2 DNA Services of America Business Overview
11.26.3 DNA Services of America Direct-to-consumer Genetic Health Sequencing Introduction
11.26.4 DNA Services of America Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.26.5 DNA Services of America Recent Development
11.27 Shuwen Health Sciences
11.27.1 Shuwen Health Sciences Company Detail
11.27.2 Shuwen Health Sciences Business Overview
11.27.3 Shuwen Health Sciences Direct-to-consumer Genetic Health Sequencing Introduction
11.27.4 Shuwen Health Sciences Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.27.5 Shuwen Health Sciences Recent Development
11.28 Mapmygenome
11.28.1 Mapmygenome Company Detail
11.28.2 Mapmygenome Business Overview
11.28.3 Mapmygenome Direct-to-consumer Genetic Health Sequencing Introduction
11.28.4 Mapmygenome Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.28.5 Mapmygenome Recent Development
11.29 Full Genomes
11.29.1 Full Genomes Company Detail
11.29.2 Full Genomes Business Overview
11.29.3 Full Genomes Direct-to-consumer Genetic Health Sequencing Introduction
11.29.4 Full Genomes Revenue in Direct-to-consumer Genetic Health Sequencing Business (2018-2025)
11.29.5 Full Genomes Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details